Image‐guided core‐needle or surgical biopsy for neuroblastoma diagnosis in children: A systematic review and meta‐analysis from the International Society of Pediatric Surgical Oncology (IPSO)

Abstract

AbstractBackgroundImage‐guided core‐needle biopsy (IGCNB) is a widely used and valuable clinical tool for tissue diagnosis of pediatric neuroblastoma. However, open surgical biopsy remains common practice even if children undergo more invasive and painful procedures. This review aims to determine the diagnostic accuracy and safety of IGCNBs in pediatric patients with neuroblastoma.MethodsWe conducted a systematic review of peer‐reviewed original articles published between 1980 and 2023, by searching “pediatric oncology,” “biopsy,” “interventional radiology,” and “neuroblastoma.” Exclusion criteria were patients older than 18 years, studies concerning non‐neurogenic tumors, case reports, and language other than English. Both the systematic review and meta‐analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement.ResultsA total of 533 abstracts articles were analyzed. Of these, eight retrospective studies met inclusion criteria (490 infants, 270 surgical biopsies [SB], 220 image‐guided biopsies). Tissue adequacy for primary diagnosis (SB: n = 265, 98%; IGCNB: n = 199, 90%; p = .1) and biological characterization (SB: n = 186, 95%; IGCNB: n = 109, 89%; p = .15) was similar with both biopsy techniques, while intraoperative transfusion rate (SB: n = 51, 22%; IGCNB: n = 12, 6%; p = .0002) and complications (%) (SB: n = 58, 21%; IGCNB: n = 14, 6%; p = .005) were higher with surgical biopsy. Length of stay was similar in both groups; however, no additional data about concurrent diagnostic or treatment procedures were available in the analyzed studies.ConclusionsIGCNB is a safe and effective strategic approach for diagnostic workup of NB and should be considered in preferance to SB wherever possible.